NCT02582697 | AGCT1532 | COG-AYA
A Randomized Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Germ Cell Tumors
6498635 | S2414 | SWOG
A Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants with Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in the AdjuvanT Setting (INSIGHT)
| FRNM-009 | DRUG CO
Blood Specimen Collection Study for Development of a Blood Test for Early Detection of Lung Cancer
NCT05136196 | S2101 | SWOG
Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) – A Phase II Study of Combining Cabozantinib and Nivolumab in Participants with Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers – an immunoMATCH Pilot Study
NCT07215624 | WF-2502CD | WAKE
Surgical Thromboprophylaxis Practices in Oncology Patients within the NCORP Network